Galactokinase (EC 2.7.1.6) (Galactose kinase) | Q9R0N0 | Exosomes from myeloid-derived suppressor cells carry biologically active proteins. J Proteome Res. 2014 Feb 7;13(2):836-43. doi: 10.1021/pr400879c. Epub 2013 Dec 13. | COG0153 | 175 / 6 / 169 |
Galactokinase (EC 2.7.1.6) (Galactose kinase) | Q9R0N0 | Exosomes from myeloid-derived suppressor cells carry biologically active proteins. J Proteome Res. 2014 Feb 7;13(2):836-43. doi: 10.1021/pr400879c. Epub 2013 Dec 13. | COG0153 | 175 / 6 / 169 |
Galactokinase (EC 2.7.1.6) (Galactose kinase) | Q9R0N0 | Membrane microvesicles as mediators for melanoma-fibroblasts communication: Roles of the VCAM-1/VLA-4 axis and the ERK1/2 signal pathway. Cancer Lett. 2015 Feb 4. pii: S0304-3835(15)00066-X. doi: 10.1016/j.canlet.2015.01.032. | COG0153 | 175 / 6 / 169 |
Galactokinase (EC 2.7.1.6) (Galactose kinase) | Q9R0N0 | Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol. 2015 May 18. doi: 10.1038/ncb3169. | COG0153 | 175 / 6 / 169 |
Galactokinase (EC 2.7.1.6) (Galactose kinase) | Q9R0N0 | A comprehensive proteomics analysis reveals a secretory path- and status-dependent signature of exosomes released from tumor associated macrophages. J Proteome Res. 2015 Aug 27. | COG0153 | 175 / 6 / 169 |
Galactokinase (EC 2.7.1.6) (Galactose kinase) | Q9R0N0 | A comprehensive proteomics analysis reveals a secretory path- and status-dependent signature of exosomes released from tumor associated macrophages. J Proteome Res. 2015 Aug 27. | COG0153 | 175 / 6 / 169 |
Galactokinase (EC 2.7.1.6) (Galactose kinase) | Q9R0N0 | Cells release subpopulations of exosomes with distinct molecular and biological properties. Sci Rep. 2016 Mar 2;6:22519. doi: 10.1038/srep22519. | COG0153 | 175 / 6 / 169 |
Galactokinase (EC 2.7.1.6) (Galactose kinase) | Q9R0N0 | Cells release subpopulations of exosomes with distinct molecular and biological properties. Sci Rep. 2016 Mar 2;6:22519. doi: 10.1038/srep22519. | COG0153 | 175 / 6 / 169 |
Galactokinase (EC 2.7.1.6) (Galactose kinase) | Q9R0N0 | Cells release subpopulations of exosomes with distinct molecular and biological properties. Sci Rep. 2016 Mar 2;6:22519. doi: 10.1038/srep22519. | COG0153 | 175 / 6 / 169 |
Galactokinase (EC 2.7.1.6) (Galactose kinase) | Q9R0N0 | Microvesicles provide a mechanism for intercellular communication by embryonic stem cells during embryo implantation. Nat Commun. 2016 Jun 15;7:11958. doi: 10.1038/ncomms11958. | COG0153 | 175 / 6 / 169 |
Galactokinase (EC 2.7.1.6) (Galactose kinase) | Q9R0N0 | Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles. Oncotarget. 2016 Jul 22. doi: 10.18632/oncotarget.10783. | COG0153 | 175 / 6 / 169 |
Galactokinase (EC 2.7.1.6) (Galactose kinase) | Q9R0N0 | Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles. Oncotarget. 2016 Jul 22. doi: 10.18632/oncotarget.10783. | COG0153 | 175 / 6 / 169 |
Galactokinase (EC 2.7.1.6) (Galactose kinase) | Q9R0N0 | Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancer. Oncotarget. 2016 Aug 23. doi: 10.18632/oncotarget.11535. | COG0153 | 175 / 6 / 169 |
Galactokinase (EC 2.7.1.6) (Galactose kinase) | Q9R0N0 | Secretome proteomics reveals candidate non-invasive biomarkers of BRCA1 deficiency in breast cancer. Oncotarget. 2016 Aug 23. doi: 10.18632/oncotarget.11535. | COG0153 | 175 / 6 / 169 |
Galactokinase (EC 2.7.1.6) (Galactose kinase) | Q9R0N0 | The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity. Cell. 2016 Dec 1;167(6):1525-1539.e17. doi: 10.1016/j.cell.2016.11.005. | COG0153 | 175 / 6 / 169 |
Galactokinase (EC 2.7.1.6) (Galactose kinase) | Q9R0N0 | The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity. Cell. 2016 Dec 1;167(6):1525-1539.e17. doi: 10.1016/j.cell.2016.11.005. | COG0153 | 175 / 6 / 169 |
Galactokinase (EC 2.7.1.6) (Galactose kinase) | Q9R0N0 | Hypoxia-induced changes in the fibroblast secretome, exosome, and whole-cell proteome using cultured, cardiac-derived cells isolated from neonatal mice. J Proteome Res. 2017 Jun 22. doi: 10.1021/acs.jproteome.7b00144. | COG0153 | 175 / 6 / 169 |
Galactokinase (EC 2.7.1.6) (Galactose kinase) | Q9R0N0 | Hypoxia-induced changes in the fibroblast secretome, exosome, and whole-cell proteome using cultured, cardiac-derived cells isolated from neonatal mice. J Proteome Res. 2017 Jun 22. doi: 10.1021/acs.jproteome.7b00144. | COG0153 | 175 / 6 / 169 |
Galactokinase (EC 2.7.1.6) (Galactose kinase) | Q9R0N0 | Proteomic profiling of exosomes secreted by breast cancer cells with varying metastatic potential. Proteomics. 2017 Nov 8. doi: 10.1002/pmic.201600370. | COG0153 | 175 / 6 / 169 |
Galactokinase (EC 2.7.1.6) (Galactose kinase) | Q9R0N0 | Proteomic profiling of exosomes secreted by breast cancer cells with varying metastatic potential. Proteomics. 2017 Nov 8. doi: 10.1002/pmic.201600370. | COG0153 | 175 / 6 / 169 |
Galactokinase (EC 2.7.1.6) (Galactose kinase) | Q9R0N0 | Proteomic profiling of exosomes secreted by breast cancer cells with varying metastatic potential. Proteomics. 2017 Nov 8. doi: 10.1002/pmic.201600370. | COG0153 | 175 / 6 / 169 |
Galactokinase (EC 2.7.1.6) (Galactose kinase) | Q9R0N0 | Proteomic profiling of exosomes secreted by breast cancer cells with varying metastatic potential. Proteomics. 2017 Nov 8. doi: 10.1002/pmic.201600370. | COG0153 | 175 / 6 / 169 |
Galactokinase (EC 2.7.1.6) (Galactose kinase) | Q9R0N0 | Differential content of proteins, mRNAs, and miRNAs suggests that MDSC and their exosomes may mediate distinct immune suppressive functions. J Proteome Res. 2017 Nov 15. doi: 10.1021/acs.jproteome.7b00646. | COG0153 | 175 / 6 / 169 |
Galactokinase (EC 2.7.1.6) (Galactose kinase) | Q9R0N0 | Differential content of proteins, mRNAs, and miRNAs suggests that MDSC and their exosomes may mediate distinct immune suppressive functions. J Proteome Res. 2017 Nov 15. doi: 10.1021/acs.jproteome.7b00646. | COG0153 | 175 / 6 / 169 |